Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
228.5 GBX | +3.86% | +12.56% | +3.86% |
08:04am | Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M | MT |
04-18 | Stifel Upgrades Oxford BioMedica to Buy from Hold, Lifts PT | MT |
Evolution of the average Target Price on Oxford Biomedica plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Oxford Biomedica plc
Stifel Nicolaus | |
Liberum Capital | |
Numis | |
JPMorgan | |
RBC Capital Markets |
EPS Revisions
- Stock Market
- Equities
- OXB Stock
- Consensus Oxford Biomedica plc